Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage.

The relationship between the presence and severity of AIDS dementia complex (ADC) and the levels of human immunodeficiency virus type 1 (HIV-1) RNA in cerebrospinal fluid (CSF) were assessed. Nineteen patients with ADC (stages 1-3), 6 without ADC (group 1), and 10 (group 2) without ADC but with cryptococcal meningitis or progressive multifocal leukoencephalopathy were studied. There was a significant relationship between increasing CSF virus burden and ADC severity (P = .0006) but not with plasma burden and ADC severity. In group 2, CSF HIV-1 RNA levels in patients with cryptococcal meningitis were elevated. These results show that CSF HIV-1 RNA concentrations correlate well with ADC severity but may also be increased by central nervous system infections, such as cryptococcal meningitis.

[1]  J. Bartlett,et al.  Amplification of HIV-1 provirus from cerebrospinal fluid and its correlation with neurologic disease. , 1990, Journal of Infectious Diseases.

[2]  J. Mills,et al.  Management of the HIV-infected patient , 1996 .

[3]  R. Miller,et al.  Expression of HIV-1 in the cerebrospinal fluid detected by the polymerase chain reaction and its correlation with central nervous system disease. , 1991, AIDS.

[4]  J. Glass,et al.  Immunocytochemical quantitation of human immunodeficiency virus in the brain: Correlations with dementia , 1995, Annals of neurology.

[5]  R. Price,et al.  The AIDS dementia complex. , 1988, The Journal of infectious diseases.

[6]  D. R. Kuritzkes,et al.  HIV viral load markers in clinical practice , 1996, Nature Medicine.

[7]  M. Rosenblum,et al.  AIDS dementia complex and HIV‐1 brain infection: Clinical‐virological correlations , 1995, Annals of neurology.

[8]  M. Moroni,et al.  High-dose nevirapine in previously untreated human immunodeficiency virus type 1-infected persons does not result in sustained suppression of viral replication. , 1997, The Journal of infectious diseases.

[9]  O. Selnes,et al.  Clinical‐neuropathologic correlation in HIV‐associated dementia , 1993, Neurology.

[10]  J. Mellors,et al.  Quantitation of HIV-1 RNA in Plasma Predicts Outcome after Seroconversion , 1995, Annals of Internal Medicine.

[11]  J. Lundgren,et al.  Longitudinal serum HIV RNA quantification: correlation to viral phenotype at seroconversion and clinical outcome , 1996, AIDS.

[12]  J. Sninsky,et al.  Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection , 1994, Journal of clinical microbiology.

[13]  O. Eeg‐Olofsson,et al.  CONCENTRATIONS OF CSF PROTEINS AS A MEASURE OF BLOOD BRAIN BARRIER FUNCTION AND SYNTHESIS OF IgG WITHIN THE CNS IN ‘NORMAL’ SUBJECTS FROM THE AGE OF 6 MONTHS TO 30 YEARS , 1981, Acta paediatrica Scandinavica.

[14]  M. Tagliati,et al.  Neurologic Manifestations of HIV Infection , 1994, Annals of Internal Medicine.